Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?

Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?

Détails bibliographiques
Auteurs principaux:	Flossmann, O, Jones, R, Jayne, DR, Luqmani, R
Format:	Journal article
Langue:	English
Publié:	2006

Documents similaires

Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
par: Mukhtyar, C, et autres
Publié: (2006)

Cardiovascular outcomes in antineutrophil cytoplasm antibody associated vasculitis (AAV)
par: Mukhtyar, C, et autres
Publié: (2008)

Is rituximab “The Wonder Drug” for antineutrophil cytoplasmic antibodies-associated vasculitis?
par: Saket Jha, et autres
Publié: (2019-01-01)

Severe Infections following Rituximab Treatment in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
par: Zhi-Ying Li, et autres
Publié: (2020-08-01)

Spotlight on rituximab in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis: current perspectives
par: Moog P, et autres
Publié: (2015-11-01)

A Case of Postcoronavirus Disease 2019 Antineutrophil Cytoplasmic Antibody-associated Vasculitis Successfully Treated with Rituximab
par: Mahmoud M. Mohamed, et autres
Publié: (2023-07-01)

Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis.
par: Walsh, M, et autres
Publié: (2011)

Glucocorticoid Treatment and Damage In The Antineutrophil- Cytoplasm Antibody Associated Vasculitides
par: Robson, J, et autres
Publié: (2013)

Early outcomes in children with antineutrophil cytoplasmic antibody-associated vasculitis
par: Morishita, K, et autres
Publié: (2017)

Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis.
par: Guerry, M, et autres
Publié: (2012)

Serum calprotectin in vasculitis associated with antineutrophil cytoplasmic antibodies
par: E. N. Vorkel, et autres
Publié: (2024-08-01)

The role of neutrophils in vasculitis associated with antineutrophil cytoplasmic antibodies
par: E. N. Vorkel, et autres
Publié: (2024-12-01)

Nailfold videocapillaroscopy in antineutrophil cytoplasmic antibody–associated vasculitis
par: Megan M. Sullivan, et autres
Publié: (2024-01-01)

Health-related quality of life after Rituximab treatment of patients with antineutrophil cytoplasmic antibody-associated vasculitis
par: Iva Parvova, et autres
Publié: (2024-11-01)

Antineutrophil cytoplasmic antibodies associated vasculitis in patient with Crohn's disease treated with adalimumab
par: Carmen Martín Varas, et autres
Publié: (2017-09-01)

Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
par: De Groot, K, et autres
Publié: (2005)

Antineutrophilic Cytoplasmic Antibody Positive Vasculitis Associated with Methimazole Use
par: Deep Shikha, et autres
Publié: (2015-01-01)

Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force.
par: Mukhtyar, C, et autres
Publié: (2008)

Rituximab in relapsed/refractory antineutrophil cytoplasmic antibody associated vasculitis: A single-center prospective observational study
par: Ekbote Gayatri, et autres
Publié: (2019-01-01)

Comparison of Two Rituximab Induction Regimens for Antineutrophil Cytoplasm Antibody–Associated Vasculitis: Systematic Review and Meta‐Analysis
par: Valérie Bénard, et autres
Publié: (2021-07-01)

Relapse Predictors in Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis
par: Katarzyna Wawrzycka-Adamczyk, et autres
Publié: (2024-08-01)

Minocycline-induced antineutrophil cytoplasmic antibody-associated vasculitis in children
par: Sunil Kapur, et autres
Publié: (2021-01-01)

Recent advances in the management of antineutrophil cytoplasmic antibody-associated vasculitis
par: Durga Prasanna Misra, et autres
Publié: (2019-01-01)

Profiles of cytokines in patients with antineutrophil cytoplasmic antibody-associated vasculitis
par: Weiwei Hao, et autres
Publié: (2024-07-01)

Treatment of Aggressive Antineutrophil Cytoplasmic Antibody–Associated Vasculitis With Eculizumab
par: Noah Huizenga, et autres
Publié: (2020-04-01)

Diagnostic algorithm for antineutrophil cytoplasmic antibody-associated systemic vasculitis
par: T V Beketova
Publié: (2018-05-01)

Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Update: Genetic Pathogenesis
par: Weiran Li, et autres
Publié: (2021-03-01)

Isolated Antineutrophil Cytoplasmic Antibody-Associated Coronary Vasculitis and Valvulitis
par: Yoon Kook Kim, MD, et autres
Publié: (2021-02-01)

A severe, antineutrophil cytoplasmic antibody associated, anterior segment vasculitis.
par: Talks, S, et autres
Publié: (1994)

Association of COVID‐19 antigenicity with the development of antineutrophilic cytoplasmic antibody vasculitis
par: Jamie R. Felzer, et autres
Publié: (2022-01-01)

Steroid-sparing strategy for the treatment of vasculitis associated with antineutrophil cytoplasmic antibodies
par: O. N. Egorova, et autres
Publié: (2024-10-01)

Caveolin-1 single nucleotide polymorphism in antineutrophil cytoplasmic antibody associated vasculitis.
par: Sourabh Chand, et autres
Publié: (2013-01-01)

Treatment With Avacopan in Patients With Respiratory Tract Manifestations of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
par: Ulrich Specks, et autres
Publié: (2025-01-01)

Antineutrophil cytoplasmic antibody-associated vasculitis in a patient with diffuse scleroderma
par: B N Shiva Prasad, et autres
Publié: (2021-01-01)

The changing paradigm of glucocorticoid therapy in antineutrophil cytoplasmic antibody-associated vasculitis
par: Kunal Chandwar, et autres
Publié: (2022-01-01)

Renal Transplantation in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Current Perspectives
par: Zdenka Hruskova, et autres
Publié: (2020-02-01)

Malignancy is increased in patients with antineutrophil cytoplasmic antibody-associated vasculitis in China
par: Xiang-Yu Han, et autres
Publié: (2024-05-01)

Treatment of severe perinuclear antineutrophil cytoplasmic antibody–associated vasculitis with efgartigimod
par: Afsoon Ghafari-Saravi, BS, et autres
Publié: (2024-05-01)

OMERACT endorsement of patient-reported outcome instruments in antineutrophil cytoplasmic antibody–associated vasculitis
par: Robson, J, et autres
Publié: (2017)

Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.
par: de Groot, K, et autres
Publié: (2009)